Medical imaging in microgravity

Aviation Space and Environmental Medicine

Volumn 71, Issue 6, 2000, Pages 640-646

  Jadvar, Hossein ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Imaging; Microgravity; MRI; PET; Space; Weightlessness

Indexed keywords

ANEMIA; ARTICLE; BONE ATROPHY; DIAGNOSTIC IMAGING; ELECTROLYTE BALANCE; FLUID SHIFT; MICROGRAVITY; MUSCLE ATROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SPACE; WEIGHTLESSNESS;

ADAPTATION, PHYSIOLOGICAL; AEROSPACE MEDICINE; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; RESEARCH; SPACECRAFT; TOMOGRAPHY, EMISSION-COMPUTED; WEIGHTLESSNESS;

EID: 0034085176     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Amidon GL, DeBrincat GA, Najib N. Effects of gravity on gastric emptying, intestinal transit, and drug absorption. J Clin Pharmacol 1991; 31(10):968-73.
2. Atkov OY, Bedneko VS, Fomina GA. Ultrasound techniques in space medicine. Aviat Space Environ Med 1987; 58:A69-73.
3. Bader A, Reimer P, Knop E, et al. An organotypical in vitro model of the liver parenchyma for uptake studies of diagnostic MR receptor agents. Magn Reson Imaging 1995; 13(7):991-1002.
4. Barrett RJ, Lokhandwala MF. Circulatory and vestibular implications of central angiotensin mechanisms in physiological adaptation to weightlessness. Med Hypotheses 1981; 7(12):1415-9.
5. Berry P, Berry I, Manelfe C. Magnetic resonance imaging evaluation of lower limb muscles during bed rest-a microgravity simulation model. Aviat Space Environ Med 1993; 64:212-8.
6. Bikle DD, Harris J, Halloran BP, Morey-Holton E. Altered skeletal pattern of gene expression in response to spaceflight and hindlimb elevation. Am J Physiol 1994; 267:E822-7.
7. Blomqvist CG. Cardiovascular adaptation to weightlessness. Med Sci Sports Exerc 1983; 15(5):428-31.
8. Bongo MW, Goldwater DJ, Popp RL, Sandler H. Echocardiographic evaluation of space shuttle crewmembers. J Appl Physiol 1987; 62(1):278-83.
9. Buckey JC Jr, Gaffney FA, Lane LD, et al. Central venous pressure in space. J Appl Physiol 1996; 81(1):19-25.
10. Budinger TF. PET instrumentation: what are the limits? Semin Nucl Med 1998; 28:247-67.
11. Chen BC, Germano G, Huang SC, et al. A new noninvasive quantification of renal blood flow with N-13 ammonia, dynamic positron emission tomography, and a two-compartment model. J Am Soc Nephrol 1992; 3(6):1295-306.
12. Connor MK, Hood DA. Effect of microgravity on the expression of mitochondrial enzymes in rat cardiac and skeletal muscles. J Appl Physiol 1998; 84(2):593-8.
13. Convertino VA. Exercise as a countermeasure for physiological adaptation to prolonged spaceflight. Med Sci Sports Exerc 1996; 28(8):999-1014.
14. Convertino VA, Doerr DF, Mathes KL, et al. Changes in volume, muscle compartment, and compliance of the lower extremities in man following 30 days of exposure to simulated microgravity. Aviat Space Environ Med 1989; 60:653-8.
15. Convertino VA, Hoffler GW. Cardiovascular physiology. Effects of microgravity. J Fla Med Assoc 1992; 79(8)517-24.
16. Desplanches D. Structural and functional adaptations of skeletal muscle to weightlessness. Int J Sports Med 1997; 18(Suppl 4):S259-64.
17. Drummer C, Heer M, Dressendorfer RA, et al. Reduced natriuresis during weightlessness. Clin Investig 1993; 71(9):678-86.
18. Edyvean J, Estenne M, Paiva M, Engel LA. Lung and chest wall mechanics in microgravity. J Appl Physiol 1991; 71(5):1956-66.
19. Elliott AR, Prisk GK, Guy HJ, West JB. Lung volumes during sustained microgravity on Spacelab SLS-1. J Appl Physiol 1994; 77(4):2005-14.
20. Engel LA. Effect of microgravity on the respiratory system. J Appl Physiol 1991; 70(5):1907-11.
21. Engelke KA, Convertino VA. Catecholamine response to maximal exercise following 16 days of simulated microgravity. Aviat Space Environ Med 1996; 67:243-47.
22. Enochs WS, Schaffer B, Bhide PG, et al. MR imaging of slow axonal transport in vivo. Exp Neurol 1993; 123(2):235-42.
23. Epstein M, DeNunzio AG, Ramachandran M. Characterization of renal response to prolonged immersion in normal man. J Appl Physiol 1980; 49(2):184-8.
24. Florence G, Lemenn M, Desert S, et al. Cerebral cortical blood flow in rabbits during parabolic flights (hypergravity and microgravity). Eur J Appl Physiol 1998; 77(5):469-78.
25. Fritsch-Yelle JM, Charles JB, Jones MM, Wood ML. Microgravity decreases heart rate and arterial pressure in humans. J Appl Physiol 1996; 80(3):910-4.
26. Gazenko OG, Genin AM, Il'in EA, et al. Physiological mechanisms of adaptation to weightlessness. Data from experiments with animals in earth-orbit biosatellites. Biol Bull Acad Sci USSR 1980; 7(1):1-12.
27. Gazenko OG, Schulzhenko EB, Egorov AD. Cardiovascular changes in prolonged space flights. Acta Physiol Pol 1986; 37(2)53-68.
28. Goda T, Takase S, Yokogoshi H, et al. Changes in hepatic metabolism through simulated weightlessness: decrease of glycogen and increase of lipids following prolonged immobilization in the rat. Res Exp Med (Berl) 1991; 191(3):189-99.
29. Goldstein DS, Chang PC, Eisenhofer G, et al. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation 1990; 81(5):1606-21.
30. Grigoriev AI, Morukov BV, Vorobiev DV. Water and electrolyte studies during long-term missions onboard the space stations SALYUT and MIR. Clin Invest 1994; 72(3):169-89.
31. Guy HJ, Prisk GK, West JB. Pulmonary function in microgravity. Physiologist 1992; 35(1 Suppl):S99-102.
32. Hargens AR, Watenpaugh DE. Cardiovascular adaptation to spaceflight. Med Sci Sports Exerc 1996; 28(8):977-82.
33. Hughes-Fulford M. Altered cell function in microgravity. Exp Gerontol 1991; 26(2-3):247-56.
34. Hughes-Fulford M. Review of the biological effects of weightlessness on the human endocrine system. Receptor 1993; 3(3):145-54.
35. Inaba T, Yamashita M, Kawase Y, et al. Quantitative measurement of renal plasma flow by positron emission tomography with oxygen -15 water. Tohoku J Exp Med 1989; 159(4):283-9.
36. Johns JP, Vernalis MN, Karemaker JM, Latham RD. Doppler evaluation of cardiac filling and ejection properties in humans during parabolic flight. J Appl Physiol 1994; 76(6):2621-6.
37. Kirsch KA, Rocker L, Gauer OH, et al. Venous pressure in man during weightlessness. Science 1984; 225(4658):218-9.
38. Korf J, Veenma-van der Duin L, Brinkman-Medema R, et al. Divalent cobalt as a label to study lymphocyte distribution using PET and SPECT. J Nucl Med 1998; 39(5):836-41.
39. Krasnov IB. Gravitational neuromorphology. Adv Space Biol Med 1994; 4:85-110.
40. Lang L, Jagoda E, Wu C, et al. Factors influencing the in vivo pharmacokinetics of peptides and antibody fragments: the pharmacokinetics of two PET-labeled low molecular weight proteins. Q J Nucl Med 1997; 41(2):53-61.
41. Leach CS, Alfrey CP, Suki WN, et al. Regulation of body fluid compartments during short-term spaceflight. J Appl Physiol 1996; 81(1):105-16.
42. Leach CS, Johnson PC. Influence of spaceflight on erythrokinetics in man. Science 1984; 225(4658):216-8.
43. LeBlanc A, Evans H, Schonfeld E, Ford J, et al. Changes in nuclear magnetic resonance (T2) relaxation of limb tissue with bed rest. Magn Reson Med 1987; 4(5):487-92.
44. LeBlanc A, Rowe R, Schneider V, et al. Regional muscle loss after short duration spaceflight. Aviat Space Environ Med 1995; 66(12):1151-4.
45. Lee VV, Kudrolli H, Marenghi J, et al. A low-cost, high-precision portable PET imaging system. [Abstract]. Proceedings of the 10th Annual International PET Conference, ICP. 1998; 30.
46. Levine DS, Greenleaf JE. Immunosuppression during spaceflight deconditioning. Aviat Space Environ Med 1998; 69:172-7.
47. Linnarsson D. Pulmonary function and cardiopulmonary interactions at microgravity. Med Sci Sports Exerc 1996; 28(10 Suppl): S14-7.
48. Michels DB, Friedman PJ, West JB. Radiographic comparison of human lung shape during normal gravity and weightlessness. J Appl Physiol 1979; 47(4):851-7.
49. Miller JD, McMillen BA, McConnaughey MM, et al. Effects of microgravity on brain neurotransmitter receptors. Eur J Pharmacol 1989; 161(2-3):165-71.
50. Moonen CT, van Zijl PC, Frank JA, et al. Functional magnetic resonance imaging in medicine and physiology. Science 1990; 250(4977):53-61.
51. Moore TP, Thornton WE. Space shuttle inflight and postflight fluid shifts measured by leg volume changes. Aviat Space Environ Med 1987; 58:A91-6.
52. Mukai CN, Lathers CM, Charles JB, et al. Acute hemodynamic responses to weightlessness during parabolic flight. J Clin Pharmacol 1991; 31(10):993-1000.
53. Newberg AB. Changes in the central nervous system and their clinical correlates during long-term spaceflight. Aviat Space Environ Med 1994; 65:562-72.
54. Nilsson D, Lennernas H, Fasth KJ, et al. Absorption of L-DOPA from the proximal small intestine studied in the rhesus monkey by positron emission tomography. Eur J Pharm Sci 1999; 7(3):185-9.
55. Paiva M, Estenne M, Engel LA. Lung volumes, chest wall configuration, and pattern of breathing in microgravity. J Appl Physiol 1989; 67(4):1542-50.
56. Palmer HE, Karagianes MT. Use of 85Sr as an indicator of bone mineral replacement in dogs after disuse demineralization. Aviat Space Environ Med 1976; 47:17-9.
57. Patwardhan AR, Evans JM, Berk M, et al. Spectral indices of cardiovascular adaptations to short-term simulated microgravity exposure. Integr Physiol Behav Sci 1995; 30(3):201-14.
58. Racine RN, Cormier SM. Effect of spaceflight on rat hepatocytes: a morphometric study. J Appl Physiol 1992; 73(2 Suppl):136S-141S.
59. Raichle ME. Imaging, the mind. Semin Nucl Med 1998; 28(4):278-89.
60. Rambaut PC, Leach CS, Johnson PC. Calcium and phosphorus change of the Apollo 17 crew members. Nutr Metab 1975; 18(2):62-9.
61. Rothenberg LN, Nath R, Price RR, et al. A perspective on the new millennium. Radiology 1998; 209:600-3.
62. Roy RR, Baldwin KM, Edgerton VR. Response of the neuromuscular unit to spaceflight: what has been learned from the rat model. Exerc Sport Sci Rev 1996; 24:399-425.
63. Rummel JA, Michel EL, Sawin CF, Buderer MC. Medical experiment M-171: results from the second manned Skylab mission. Aviat Space Environ Med 1976; 47:1056-60.
64. Santens P, De Vos F, Thierens H, et al. Biodistribution and dosimetry of carbon-11-methoxyprogabidic acid, a possible ligand for GABA-receptors in brain. J Nucl Med 1998; 39(2):307-10.
65. Schoepf U, Marecos EM, Melder RJ, et al. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 1998; 24(4):642-6, 648-51.
66. Schuster DP. The evaluation of lung function with PET Semin Nucl Med 1998; 28(4):341-51.
67. Shreve P, Chiao PC, Humes HD, et al. Carbon-11-acetate PET imaging in renal disease. J Nucl Med 1995; 36(9):1595-601.
68. Shykoff BE, Farhi LE, Olszowka AJ, et al. Cardiovascular response to submaximal exercise in sustained microgravity. J Appl Phys 1996; 81(1):26-32.
69. Stein TP, Schluter MD. Human skeletal muscle protein breakdown during spaceflight. Am J Physiol 1997; 272(4 Pt 1):E688-95.
70. Sugawara M, Oku N, Tsukada H, et al. Site-specific protein synthesis in liver regeneration determined by PET. J Nucl Med 1995; 36(4):628-31.
71. Swenson DA. Status of our PET linac design. [Abstract]. Proceedings of the 10th Annual International PET Conference, ICP. 1998; 31.
72. Taniguchi H, Oguro A, Takeuchi K, et al. Difference in regional hepatic blood flow in liver segments: non-invasive measurement of regional hepatic arterial and portal blood flow in human by positron emission tomography with H2(15)O. Ann Nucl Med 1993; 7(3):141-5.
73. Tavassoli M. Anemia of spaceflight. Blood 1982; 60(5):1059-67.
74. Thapar K, Kovacs K, Horvath E, et al. Effects of spaceflight on the rat adenohypophysis. J Appl Physiol 1994; 77(3):1411-20.
75. Thornton WE, Moore TP, Pool SL. Fluid shifts in weightlessness. Aviat Space Environ Med 1987; 58:A86-90.
76. Tietze KJ, Putcha L. Factors affecting drug bioavailability in space. J Clin Pharmacol 1994; 34(6):671-6.
77. Tipton CM, Greenlead JE, Jackson CG. Neuroendocrine and immune system responses with spaceflights. Med Sci Sports Exerc 1996; 28(8):988-98.
78. Tipton CM, Sebastian LA. Dobutamine as a countermeasure for reduced exercise performance of rats exposed to simulated microgravity. J Appl Physiol 1997; 82(5):1607-15.
79. Townsend DW, Beyer T, Kinahan P, et al. The SMART scanner: a combined PET/CT tomograph for clinical oncology. [Abstract]. Radiology 1998; 209(P):169.
80. Tweson TJ, Krohn KA. PET radiopharmaceuticals: state of the art and future prospects. Semin Nucl Med 1998; 28:221.
81. Vaitl D, Gruppe H, Stark R, Possel P. Simulated microgravity and cortical inhibition: a study of the hemodynamic-brain interaction. Biol Psych 1996; 42(1-2):87-103.
82. Verbanck S, Larsson H, Linnarsson D, et al. Pulmonary tissue volume, cardiac output, and diffusing capacity in sustained microgravity. J Appl Physiol 1997; 83(3):810-6.
83. Weissleder R, Lee AS, Khaw BA, et al. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 1992; 182(2):381-5.
84. Weissleder R, Simonova M, Bogdanova A, et al. MR imaging and scintigraphy of gene expression through melanin induction. Radiology 1997; 204:425-9.
85. West JB, Elliot AR, Guy HJB, Prisk GK. Pulmonary function in space. JAMA 1997; 277(24):1957-61.
86. Whitson PA, Pietrzyk RA, Pak CY, Cintron NM. Alteration in renal stone risk factors after space flight. J Urol 1993; 150(3): 803-7.
87. Wood MJ, Wood CD, Manno JE, et al. Nuclear medicine evaluation of motion sickness and medications on gastric emptying time. Aviat Space Environ Med 1987; 58:1112-4.
88. Yamamura N, Magata Y, Kitano H, et al. Evaluation of [1-11C]octanoate as a new radiopharmaceutical for assessing liver function using positron emission tomography. Nucl Med Biol 1998; 25(5):467-72.